Catharina Ziekenhuis Eindhoven
catharinaziekenhuis.nlLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
82
Active
9
Phase 3
2
Total enrollment
18,426
Pipeline matrix
Showing 2 of 2 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Combination drug | — | — | — | — | — | 1 | |
| Imiquimod | — | — | — | — | — | 1 |
Next readouts
- 2024-03-01
- 2024-12
Top conditions
- Coronary Artery Disease6
- Heart Failure4
- Atrial Fibrillation4
- Osteoporosis3
- Cardiac Output, High3
- Acute Myocardial Infarction3
- Intubation Complication3
- Critical Illness2
Frequently asked questions about Catharina Ziekenhuis Eindhoven
- How many clinical trials does Catharina Ziekenhuis Eindhoven have on ClinicalTrials.gov?
- Catharina Ziekenhuis Eindhoven is listed as the lead sponsor on 82 clinical trials in ClinicalTrials.gov, 9 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Catharina Ziekenhuis Eindhoven's trials are in Phase 3?
- 2 of Catharina Ziekenhuis Eindhoven's trials are in Phase 3, spread across 2 active drug programs.
- What therapeutic areas does Catharina Ziekenhuis Eindhoven focus on?
- Catharina Ziekenhuis Eindhoven's most-studied conditions on ClinicalTrials.gov are Coronary Artery Disease, Heart Failure, Atrial Fibrillation, Osteoporosis, Cardiac Output, High.
- When are Catharina Ziekenhuis Eindhoven's next clinical trial readouts?
- Catharina Ziekenhuis Eindhoven has 2 upcoming primary-completion readouts tracked here; the soonest is “Induction Chemotherapy for Locally Recurrent Rectal Cancer”, expected around 2024-03-01.